- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 24, 2025 | 80.5M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.44B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.41B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $8.73M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $8.14M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $408.97M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $411.45M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $568.75M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $566.38M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.24B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.2B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $727.24M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $710.53M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.69B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.65B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $88.36M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 79.95M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $26.88M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $1.35M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.22 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.22 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $87.13M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $861K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$17.96M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $25.81M |
| Revenue | Q1 2025 · Mar 31, 2024 | $600.32M |